Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.

Part of paid clinical trials in Milwaukee, Wisconsin.

Sponsor
Medical College of Wisconsin
Study ID
NCT06617949
Phase
EARLY_PHASE1
Status
Recruiting

Conditions

  • Substance Use Disorder (SUD)

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 40 Years
Healthy Volunteers
Not accepted

Interventions

  • Regional Anesthesia — DRUG
    Transverse abdominal Plane(TAP) Block with long acting Exparel placed by a regional anesthesiologist.
  • Hydromorphone Patient Controlled Analgelsic — DRUG
    This group will be administered epidural PCA as a modality for pain control post cesarian section
  • Epidural local anesthetic infusion — PROCEDURE
    Epidural group will receive pain control via a local anesthetic intermediate bolus infusion

Study Details

The purpose of this study is to investigate the efficacy of three different modalities of post-operative pain control in parturient with opioid use disorders. The investigators aim to determine whether the different approach utilized show better outcomes with pain management and if there are any association with reduction of symptoms of anxiety, depression, and overall well-being.

Key Dates

Start date
Jan 16, 2025
Status verified
Oct 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Transverse abdominal Plane(TAP) Block with long acting Exparel
    A subset of participants (n=15) will be divided into three different arms: A.) Postoperative Epidural infusion for 24-36hrs B.) Hydromorphone Patient Controlled Analgesia (PCA) with Preservative free Morphine via epidural for 36hrs C.) Transverse abdominal Plane(TAP) Block with long acting Exparel.
  • Active Comparator: Postoperative Epidural infusion for 24-36hrs
    A subset of participants (n=15) will be divided into three different arms: A.) Postoperative Epidural infusion for 24-36hrs B.) Hydromorphone Patient Controlled Analgesia (PCA) with Preservative free Morphine via epidural for 36hrs C.) Transverse abdominal Plane(TAP) Block with long acting Exparel.
  • Active Comparator: Hydromorphone Patient Controlled Analgesia (PCA),Preservative free Morphine via epidural for 36hrs
    A subset of participants (n=15) will be divided into three different arms: A.) Postoperative Epidural infusion for 24-36hrs B.) Hydromorphone Patient Controlled Analgesia (PCA) with Preservative free Morphine via epidural for 36hrs C.) Transverse abdominal Plane(TAP) Block with long acting Exparel.

Primary Outcome Measure

Number of participants with Change in pain assessment scores from baseline post surgery [ Time Frame: immediately after the study intervention and up to post op day 2 ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Froedtert HospitalMilwaukeeWisconsin53226
Meredith Albrecht, MD,PhD
414-805-8700
Froedtert Hospital Milwaukee, Wisconsin 53226MilwaukeeWisconsin53226
Christopher Fadumiye

Find similar trials in Milwaukee, WI

Related Studies